Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT.

Michael SørensenMette Marie FodeJørgen Baltzer PetersenMarianne Ingerslev HoltMorten Høyer

Published in: Radiation oncology (London, England) (2021)

[18F]FDGal PET/CT makes it possible to determine a dose-response relationship between radiation dose and metabolic liver function, here with a TD50 of 18 Gy (95% CI 12-26 Gy). Moreover, the method makes it possible to estimate metabolic recovery in liver tissue.

Keyphrases

pet ct
positron emission tomography
end stage renal disease
ejection fraction
chronic kidney disease
early stage
squamous cell carcinoma
radiation induced
high resolution
mass spectrometry
rectal cancer
single molecule